Shionogi Pharma, Inc. to Halve US Sales Force as Generics Hit Former Sciele Pharma, Inc. Business

Script Intelligence -- Shionogi is to slash the number of sales reps it employs in the US by around 50%, in a major restructuring following its 2008 acquisition of Sciele Pharma.